By Jonathan Stempel NEW YORK (Reuters) – Pfizer (NYSE:PFE) will pay $59.7 million to resolve charges that a company it acquired defrauded Medicare and other healthcare programs by paying kickbacks so doctors would prescribe the migraine drug Nurtec ODT,

By Jessica DiNapoli and Jonathan Stempel NEW YORK (Reuters) – Ben & Jerry’s on Friday ratcheted up its censorship lawsuit against Unilever (LON:ULVR), accusing its parent company of suppressing a social policy statement the U.S. ice cream maker wanted

By Dietrich Knauth NEW YORK (Reuters) – Purdue Pharma said on Friday it needs more time to build support for a new $7.4 billion settlement that could complete the company’s years-long effort to resolve thousands of lawsuits over its addictive pain

By Tim McLaughlin and Laila Kearney (Reuters) – President Donald Trump’s oversight of an increasingly unreliable U.S. power grid requires swift action, he said this week, but there is no easy fix for one of the grid’s most complex and troubled

By Sarah N. Lynch WASHINGTON (Reuters) -U.S. President Donald Trump’s administration has halted all pending environmental litigation and reassigned four career Justice Department attorneys focused on environmental issues, according to three sources familiar with the matter and a pair of memos